Pacifichealth Laboratories Stock Price To Earnings To Growth
PHLIDelisted Stock | USD 0.0001 0.00 0.00% |
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company Price To Earnings To Growth Analysis
PacificHealth Laboratories' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, PacificHealth Laboratories has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Personal Products sector and 100.0% lower than that of the Consumer Staples industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
All Next | Launch Module |
PacificHealth Fundamentals
Return On Equity | -0.75 | ||||
Return On Asset | -0.25 | ||||
Profit Margin | (0.14) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 571.89 K | ||||
Shares Outstanding | 20.87 M | ||||
Price To Earning | (0.34) X | ||||
Price To Book | 0.71 X | ||||
Price To Sales | 0.07 X | ||||
Revenue | 6.91 M | ||||
Gross Profit | 2.99 M | ||||
EBITDA | (861.23 K) | ||||
Net Income | (486.31 K) | ||||
Cash And Equivalents | 324.48 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 54.86 K | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 0.04 X | ||||
Cash Flow From Operations | (503.96 K) | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 2.8 | ||||
Beta | -275.06 | ||||
Market Capitalization | 87 | ||||
Total Asset | 1.89 M | ||||
Retained Earnings | (20.59 M) | ||||
Working Capital | 676 K | ||||
Current Asset | 1.84 M | ||||
Current Liabilities | 1.17 M | ||||
Z Score | -11.0 | ||||
Net Asset | 1.89 M |
About PacificHealth Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PacificHealth Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PacificHealth Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PacificHealth Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |